1. Home
  2. EVO vs INMD Comparison

EVO vs INMD Comparison

Compare EVO & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • INMD
  • Stock Information
  • Founded
  • EVO 1993
  • INMD 2008
  • Country
  • EVO Germany
  • INMD Israel
  • Employees
  • EVO N/A
  • INMD N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EVO Health Care
  • INMD Health Care
  • Exchange
  • EVO Nasdaq
  • INMD Nasdaq
  • Market Cap
  • EVO 1.5B
  • INMD 1.5B
  • IPO Year
  • EVO 2021
  • INMD 2019
  • Fundamental
  • Price
  • EVO $4.11
  • INMD $16.79
  • Analyst Decision
  • EVO Buy
  • INMD Buy
  • Analyst Count
  • EVO 2
  • INMD 6
  • Target Price
  • EVO $5.90
  • INMD $22.40
  • AVG Volume (30 Days)
  • EVO 184.0K
  • INMD 947.3K
  • Earning Date
  • EVO 11-06-2024
  • INMD 02-04-2025
  • Dividend Yield
  • EVO N/A
  • INMD N/A
  • EPS Growth
  • EVO N/A
  • INMD N/A
  • EPS
  • EVO N/A
  • INMD 1.84
  • Revenue
  • EVO $866,665,179.00
  • INMD $423,746,000.00
  • Revenue This Year
  • EVO $3.89
  • INMD N/A
  • Revenue Next Year
  • EVO $9.65
  • INMD $2.48
  • P/E Ratio
  • EVO N/A
  • INMD $9.14
  • Revenue Growth
  • EVO N/A
  • INMD N/A
  • 52 Week Low
  • EVO $2.85
  • INMD $14.87
  • 52 Week High
  • EVO $8.39
  • INMD $26.80
  • Technical
  • Relative Strength Index (RSI)
  • EVO 42.87
  • INMD 46.02
  • Support Level
  • EVO $4.00
  • INMD $15.43
  • Resistance Level
  • EVO $4.63
  • INMD $16.80
  • Average True Range (ATR)
  • EVO 0.14
  • INMD 0.50
  • MACD
  • EVO -0.04
  • INMD 0.03
  • Stochastic Oscillator
  • EVO 16.88
  • INMD 67.33

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Share on Social Networks: